{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:46:46Z","timestamp":1761896806197},"reference-count":29,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2018,8,3]]},"DOI":"10.1080\/13696998.2018.1474745","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T19:33:02Z","timestamp":1525894382000},"page":"793-798","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Healthcare resource utilization with ixazomib or placebo plus lenalidomide-dexamethasone in the randomized, double-blind, phase 3 TOURMALINE-MM1 study in relapsed\/refractory multiple myeloma"],"prefix":"10.1080","volume":"21","author":[{"given":"Parameswaran","family":"Hari","sequence":"first","affiliation":[{"name":"Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huamao Mark","family":"Lin","sequence":"additional","affiliation":[{"name":"Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Berg","sequence":"additional","affiliation":[{"name":"Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G.","family":"Richardson","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, MA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Moreau","sequence":"additional","affiliation":[{"name":"University Hospital H\u00f4tel Dieu, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,5,29]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21387"},{"key":"CIT0002","unstructured":"National Cancer Institute. Bethesda, MD, USA. Surveillance, epidemiology and end results (SEER) program. Cancer Stat Facts: Myeloma. https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html, based on November 2017 SEER data submission, posted to the SEER web site, April 2018."},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2017.0023"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2017.03.018"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70440-1"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606038"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607751"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505654"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411321"},{"key":"CIT0010","unstructured":"Velcade\u00ae (bortezomib) for injection. United States Prescribing Information. 06\/2017"},{"key":"CIT0011","unstructured":"KYPROLIS\u00ae (carfilzomib) for injection, for intravenous use. United States Prescribing Information. 05\/2017"},{"key":"CIT0012","unstructured":"KYPROLIS European Product Assessment Report \u2013 Product Information. 2017"},{"key":"CIT0013","unstructured":"NINLARO\u00ae (ixazomib) capsules, for oral use. United States Prescribing Information. 11\/2016"},{"key":"CIT0014","unstructured":"NINLARO European Product Assessment Report \u2013 Product Information. 2016"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516282"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-791228"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.2466"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402551"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1177772"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.380"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2009.01153.x"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12020"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0113"},{"key":"CIT0024","first-page":"204","volume":"8","author":"Roy A","year":"2015","journal-title":"Am Health Drug Benefits"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.170118"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.34.15_suppl.6621"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2644-6"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00371-9"},{"key":"CIT0029","first-page":"595","volume":"102","author":"Tatarczuch M","year":"2017","journal-title":"Haematologica"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2018.1474745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:13:33Z","timestamp":1597191213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2018.1474745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,29]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8,3]]}},"alternative-id":["10.1080\/13696998.2018.1474745"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2018.1474745","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-02-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}